Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...
BOSTON--(BUSINESS WIRE)--Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), today announced that patients treated with the ...
There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at ...
Catherine, born with Down syndrome and Tetralogy of Fallot (TOF), a rare congenital heart condition, has regained her quality of life after undergoing a novel Venus P™ valve implantation at the ...
According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...
A joint study by the University Medical Center Göttingen (UMG) and the University Hospital Würzburg provides new insights ...
For the first time researchers are beginning to understand exactly how various forms of exercise impact the heart. Massachusetts General Hospital (MGH) investigators, in collaboration with the Harvard ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback